113 related articles for article (PubMed ID: 9633565)
1. Science, lawyers, and "the Europeans": testing requirements in transfusion medicine.
Seitz R; Burger R
Transfusion; 1998 May; 38(5):506-7. PubMed ID: 9633565
[No Abstract] [Full Text] [Related]
2. Emerging viruses and transfusion.
Allain JP
Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
[TBL] [Abstract][Full Text] [Related]
3. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
4. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
Roth WK; Seifried E
Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
[No Abstract] [Full Text] [Related]
5. [Current tactics in reducing hazards of virus infection transmission during blood transfusion].
Golosova TV
Gematol Transfuziol; 1992 Mar; 37(3):35-7. PubMed ID: 1516800
[No Abstract] [Full Text] [Related]
6. Consequences of nucleic acid amplification testing for blood transfusion centres.
Reesink HW; Engelfriet CP; Vrielink H; Krusius T; Lankinen M; Flanagan P; Barbara J; Gill P; Dodd RY; Busch MP; Prati D; Mozzi F; Sirchia G; Diekamp U; Epstein JS; Tabor E; Martin-Vega C; Hernândez JM
Vox Sang; 1998; 74(4):263-70. PubMed ID: 9691411
[No Abstract] [Full Text] [Related]
7. Sensitivity of HCV RNA and HIV RNA blood screening assays.
Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
[TBL] [Abstract][Full Text] [Related]
8. [Transfusion safety and hemosurveillance].
Romeiras MC
Acta Med Port; 2000; 13(4):199-202. PubMed ID: 11155487
[TBL] [Abstract][Full Text] [Related]
9. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
10. Trends in the prevalence of transfusion-transmissible infections among blood donors in Albania.
Durro V; Koraqi A; Saliasi S
Clin Lab; 2010; 56(11-12):591-5. PubMed ID: 21141446
[TBL] [Abstract][Full Text] [Related]
11. On the prevention of viral transmitted infections in plasma products.
Martin W
Dev Biol Stand; 1987; 67():233-6. PubMed ID: 3038637
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
[TBL] [Abstract][Full Text] [Related]
13. [Transfusions of blood and blood products and virus infections].
Wróblewska M; Piotrowska E; ĺuczak M
Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
[TBL] [Abstract][Full Text] [Related]
14. Safety monitoring and epidemiological surveillance of blood transfusion in Europe.
Van Aken WG
Transfus Clin Biol; 1995; 2(1):13-5. PubMed ID: 7728264
[No Abstract] [Full Text] [Related]
15. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
Mueller MM; Seifried E
Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
[TBL] [Abstract][Full Text] [Related]
16. Development of working reagents and international standards.
Saldanha J
Biologicals; 1998 Jun; 26(2):115-7. PubMed ID: 9811516
[No Abstract] [Full Text] [Related]
17. Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors.
Blair CS; Davidson F; Lycett C; McDonald DM; Haydon GH; Yap PL; Hayes PC; Simmonds P; Gillon J
J Infect Dis; 1998 Dec; 178(6):1779-82. PubMed ID: 9815233
[TBL] [Abstract][Full Text] [Related]
18. Sequential serologic testing for common viral markers in blood units in India is probably not cost-effective.
Ghosh K; Ghosh K
Transfusion; 2010 Aug; 50(8):1854-5. PubMed ID: 20883257
[No Abstract] [Full Text] [Related]
19. Transfusion and the human immunodeficiency virus.
Balfour HH
Transfusion; 1993 Feb; 33(2):101-2. PubMed ID: 8430445
[No Abstract] [Full Text] [Related]
20. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
